Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer

Histopathology

Volumn 59, Issue 2, 2011, Pages 198-206

  Xing, Xiao Fang ^a   Li, Hong ^b   Zhong, Xi Yao ^a   Zhang, Lian Hai ^a   Wang, Xiao Hong ^a   Liu, Yi Qiang ^a,b   Jia, Shu Qin ^a   Shi, Tao ^a   Niu, Zhao Jian ^c   Peng, Yong ^a   Du, Hong ^d   Zhang, Gui Guo ^d   Hu, Ying ^d   Lu, Ai Ping ^a   Li, Ji You ^a   Chen, She ^b   Ji, Jia Fu ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^c SHANDONG UNIVERSITY   (China)

^d Tissue Bank ^*  (United States)

Author keywords

Intestinal metaplasia; Phospholipase A2 group IIA; Prognosis; Stomach neoplasms

Indexed keywords

LYSOZYME; PHOSPHOLIPASE A2 GROUP II;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANETH CELL; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHINA; FEMALE; GROUP II PHOSPHOLIPASES A2; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MURAMIDASE; NEOPLASM INVASIVENESS; PANETH CELLS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 80052247350     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03913.x     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55; 74-108.
2. Leung SY, Chen X, Chu KM et al. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc. Natl Acad. Sci. USA 2002; 99; 16203-16208.
3. Praml C, Amler LC, Dihlmann S, Finke LH, Schlag P, Schwab M. Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa. Oncogene 1998; 17; 2009-2012.
4. Fijneman RJ, Cormier RT. The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine. Front. Biosci. 2008; 13; 4144-4174.
5. Singh N, Jabeen T, Sharma S et al. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution. Acta Crystallogr. D Biol. Crystallogr. 2006; 62; 410-416.
6. Lands WE. Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis. J. Biol. Chem. 1958; 231; 883-888.
7. Graham DY, Chan FK. NSAIDs, risks, and gastroprotective strategies: current status and future. Gastroenterology 2008; 134; 1240-1246.
8. Nevalainen TJ, Gronroos JM, Kallajoki M. Expression of group II phospholipase A2 in the human gastrointestinal tract. Lab. Invest. 1995; 72; 201-208.
9. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 2000; 1; 113-118.
10. Cormier RT, Hong KH, Halberg RB et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet. 1997; 17; 88-91.
11. Min/+ Mom1S mice. Proc. Natl Acad. Sci. USA 2005; 102; 2868-2873.
12. Ganesan K, Ivanova T, Wu Y et al. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Res. 2008; 68; 4277-4286.
13. Buhmeida A, Bendardaf R, Hilska M et al. PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma. Ann. Oncol. 2009; 20; 1230-1235.
14. Kashiwagi M, Friess H, Uhl W et al. Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis. Gut 1999; 45; 605-612.
15. Masty J, Stradley RP. Paneth cell degranulation and lysozyme secretion during acute equine alimentary laminitis. Histochemistry 1991; 95; 529-533.
16. Keshav S. Paneth cells: leukocyte-like mediators of innate immunity in the intestine. J. Leukoc. Biol. 2006; 80; 500-508.
17. Mounier CM, Wendum D, Greenspan E, Flejou JF, Rosenberg DW, Lambeau G. Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate. Br. J. Cancer 2008; 98; 587-595.
18. Laye JP, Gill JH. Phospholipase A2 expression in tumours: a target for therapeutic intervention? Drug Discov. Today 2003; 8; 710-716.
19. Cummings BS. Phospholipase A2 as targets for anti-cancer drugs. Biochem. Pharmacol. 2007; 74; 949-959.
20. Graff JR, Konicek BW, Deddens JA et al. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade. Clin. Cancer Res. 2001; 7; 3857-3861.
21. Jiang J, Neubauer BL, Graff JR et al. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am. J. Pathol. 2002; 160; 667-671.
22. Birts CN, Barton CH, Wilton DC. Catalytic and non-catalytic functions of human IIA phospholipase A2. Trends Biochem. Sci. 2010; 35; 28-35.
23. Fijneman RJ, Peham JR, Van de Wiel MA et al. Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice. Cancer Sci. 2008; 99; 2113-2119.
24. Silverman KA, Koratkar R, Siracusa LD, Buchberg AM. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Res. 2002; 12; 88-97.
25. Fijneman RJ, Bade LK, Peham JR et al. Pla2g2a attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice; expression studies reveal Pla2g2a target genes and pathways. Cell. Oncol. 2009; 31; 345-356.
26. Chan TA. Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol. 2002; 3; 166-174.
27. Jolly K, Cheng KK, Langman MJ. NSAIDs and gastrointestinal cancer prevention. Drugs 2002; 62; 945-956.
28. Min/+ tumorigenesis. Oncogene 2005; 24; 6450-6458.
29. Stappenbeck TS. Paneth cell development, differentiation, and function: new molecular cues. Gastroenterology 2009; 137; 30-33.
30. Babu A, Mauchley D, Meng X et al. The secretory phospholipase A2 gene is required for gastroesophageal reflux-related changes in murine esophagus. J. Gastrointest. Surg. 2009; 13; 2212-2218.